ENSEM Therapeutics Funding: $67M Raised, Series A (2022)
ENSEM Therapeutics is based in Cambridge. It has raised $67M in total funding. Latest round: Series A.
ENSEM Therapeutics funding overview
ENSEM Therapeutics is based in Cambridge. ENSEM Therapeutics has raised $67M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in April 2022. The round record for ENSEM Therapeutics runs through 2022; nothing later has been disclosed. Investors on record include GGV Capital, Pavilion Capital, Cenova Ventures, Mitsui & Co. Global Investment, CBC Group. 5 distinct backers are named across the disclosed rounds.
ENSEM Therapeutics at a glance
Total raised
$67M
Latest round
Series A
Latest round date
April 2022
Headquarters
Cambridge
Notable investors
GGV Capital, Pavilion Capital, Cenova Ventures, Mitsui & Co. Global Investment, CBC Group
Frequently asked about ENSEM Therapeutics funding
How much has ENSEM Therapeutics raised?
ENSEM Therapeutics has raised $67M in total disclosed funding across the rounds on record.
Who has invested in ENSEM Therapeutics?
GGV Capital, Pavilion Capital, Cenova Ventures, Mitsui & Co. Global Investment, CBC Group are named among the investors backing ENSEM Therapeutics.
What was the latest ENSEM Therapeutics funding round?
The most recent disclosed round is a Series A, announced in April 2022.
Where is ENSEM Therapeutics based?
ENSEM Therapeutics is based in Cambridge.
When did ENSEM Therapeutics last raise?
The last disclosed ENSEM Therapeutics round closed in April 2022 at Series A.
Every ENSEM Therapeutics figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Cambridge at a similar stage.
